Exelixis partners with Roche to evaluate advanced solid tumor therapies
  Author: Saipriya Iyer

Exelixis Inc., a California-based drug discovery firm that focuses on discovering, developing and then commercializing d...

Read More
MODAG starts first-in-human Phase 1 clinical trial for Anle138b
  Author: Pankaj Singh

MODAG has announced the start of clinical trial and recruitment for a first-in-human Phase 1 study of Anle 138b in hea...

Read More
The Lancet publishes Phase 3 trial results of FINTEPLA® of Zogenix
  Author: Saipriya Iyer

Zogenix, a renowned US-based pharmaceutical company, reportedly announced that The Lancet, a renowned medical journal,...

Read More
Walgreens Boots Alliance inks deal with McKesson Corporation
  Author: Saipriya Iyer

Walgreens Boots Alliance, an American holding company headquartered in Illinois inked a deal with Mckesson Corporation...

Read More
Amphivena announces initial data from Phase 1 study of AMV564
  Author: Saipriya Iyer

Amphivena Therapeutics, Inc., a clinical stage immuno-oncology firm developing T cell engager therapies for cancer, ha...

Read More
Sanofi to acquire biotechnology firm Synthorx for $2.5 billion
  Author: Saipriya Iyer

Sanofi, a renowned France based multinational pharmaceutical company, reportedly announced that it would be acquiring ...

Read More
GE Healthcare Life Sciences & ASLS unite to advance 3D biofabrication
  Author: Pankaj Singh

  The alliance is aimed at personalizing regenerative tissue manufacturing processes ...

Read More
uniQure updates follow up-data from hemophilia B therapy trials
  Author: Saipriya Iyer

uniQure N.V, a renowned gene therapy firm that advances evolving therapies for all the patients who have severe medica...

Read More
Hummingbird Bio secures $19M to expand antibody therapeutics portfolio
  Author: Pankaj Singh

Hummingbird Bioscience, an advanced biotherapeutics company, recently announced it has raised USD 19 million in a Seri...

Read More
Acadia announces positive results of Phase 3 trial to treat psychosis
  Author: Pankaj Singh

Acadia Pharmaceuticals, a renowned US-based biopharmaceutical company dedicated to the development of treatments for c...

Read More
Veracyte inks deal with NanoString for nCounter® diagnostic platform
  Author: Saipriya Iyer

San-Francisco based leading diagnostics company Veracyte has recently announced a definitive agreement with NanoString...

Read More
Senseonics’ Eversense® obtains non-adjunctive labeling claim in U.S.
  Author: Pankaj Singh

Senseonics Holdings, Inc., a US-based medical device startup company recently announced that users of its Eversen...

Read More
Astellas Pharma inks a $3 Bln deal to acquire Audentes Therapeutics
  Author: Pankaj Singh

Japanese pharmaceutical company, Astellas Pharma Inc. has reportedly entered into a definitive agreement to acquire bi...

Read More
FDA accepts NDA for Pemigatinib, announces Innovent Biologics
  Author: Pankaj Singh

  Pemigatinib has been granted priority review by the FDA ...

Read More
Jubilant Biosys to begin expansion of its drug discovery services
  Author: Saipriya Iyer

Jubilant Biosys, a Jubilant Lifesciences Limited subsidiary based in Bengaluru, recently announced it will be starting...

Read More
Emerald Healths Pure Sunfarms signs cannabis supply deal with AGLC
  Author: Saipriya Iyer

Emerald Health Therapeutics, a renowned Canada-based licensed medical cannabis producer, reportedly announced that its 50% owned subsidiary, Pure S...

Read More
Bio-Path Holdings finalizes safety testing in Phase 2 trial targeting AML
  Author: Pankaj Singh

Bio-Path Holdings Inc., a biotechnology company developing novel therapeutics, has reportedly announced the successful...

Read More
Intuitive’s E-100 generator and SynchroSeal gets the FDA clearance
  Author: Pankaj Singh

Intuitive, a US-based developer, manufacturer, and marketer of the robotic products designed to improve clinical resul...

Read More
Ferring and Blackstone jointly invest in a new bladder cancer therapy
  Author: Pankaj Singh

Private investment firm, Blackstone Life Sciences and Ferring Pharmaceuticals recently announced joint investment of m...

Read More
AVITA Medical & Gates Center unite to explore spray-on skin treatment
  Author: Pankaj Singh

AVITA Medical and Gates Center for Regenerative Medicine have reportedly inked a Sponsored Research Agreement or SRA t...

Read More
Anelixis announces the conclusion of AT-1501 Phase 1 clinical trial
  Author: Saipriya Iyer

Anelixis Therapeutics has reportedly concluded its testing of an investigational antibody, AT-1501, in a Phase 1 clini...

Read More
European Commission approves Merck KEYTRUDA as a HNSCC treatment
  Author: Saipriya Iyer

Merck, a renowned American pharmaceutical firm and one of the largest pharmaceutical companies in the world reportedly...

Read More
Early data from first human CRISPR trials reveals promising results
  Author: Pankaj Singh

Vertex Pharmaceuticals and CRISPR Therapeutics have recently revealed early data from their joint trials to test CRISP...

Read More
Triple Gene releases Phase 1 study data for INXN-4001 in heart failure
  Author: Saipriya Iyer

Triple Gene LLC- a U.S. based cardiovascular gene therapy enterprise recently furnished preliminary data from its Phas...

Read More
Novartis’ trial of Entresto reveals potential beyond HFrEF treatment
  Author: Pankaj Singh

Swiss pharma-company Novartis has reportedly revealed subgroup results from its global PARAGON-HF Phase III study. The...

Read More
Stanford medicine releases its research on Apple Heart watches
  Author: Pankaj Singh

The study comprised enrollment of over 400,000 people, making it one of the biggest research efforts....

Read More
Daiichi Sankyo announces positive results from Phase 3 pivotal trial
  Author: Saipriya Iyer

Daiichi Sankyo Company, Limited (hereafter Daiichi Sankyo), today made a breakthrough announcement stating that the ma...

Read More
WeChat Pay & Alipay allow overseas users to use international cards
  Author: Pankaj Singh

On the foundation of the popular digital payment services, China is moving towards a cashless economy. In a bid to off...

Read More
CANbridge Pharmaceuticals receives registration approval for NERLYNX®
  Author: Saipriya Iyer

Puma Biotechnology, Inc. has reportedly announced that its licensing partner CANbridge Pharmaceuticals Inc., based in ...

Read More
Melanoma Research Alliance raises $20M for new research program
  Author: Saipriya Iyer

Of late, several medical firms and associations are carrying out novel research programs and funding to support their ...

Read More
Savonix and Boston University to digitally gather cognitive health data
  Author: Saipriya Iyer

Savonix Inc.- a U.S. based company dedicated towards providing digital tests for cognitive health and Boston University- a global leading school fo...

Read More
China gives nod to new seaweed-based Alzheimer’s drug Oligomannate
  Author: Saipriya Iyer

The Chinese government has reportedly approved world’s first drug in 20 years for treating Alzheimer’s dis...

Read More
Knight & TherapeuticsMD amid filing a NDS for Joyesta™ in Canada
  Author: Pankaj Singh

Knight Therapeutics Inc., a pharmaceutical company based in Canada, had last year entered a ...

Read More
Themis Bioscience, CEPI initiate Phase 1 study for Lassa Fever vaccine
  Author: Pankaj Singh

Lassa fever is a severe viral hemorrhagic illness which usually occurs due to human exposure to infected food or house...

Read More
Mirati Therapeutics reveals Phase ½ results of KRAS inhibitor therapy
  Author: Pankaj Singh

Mirati Therapeutics, an oncology company that engages in the development of targeted therapies, recently released its ...

Read More
Nature Tech Corp partners with Aldevron for gene therapy manufacturing
  Author: Pankaj Singh

The global cell and gene therapy sector is expected to witness a thriving period of growth over the forthcoming years....

Read More
Genentech IMbrave150 study meets coprimary endpoints for HCC treatment
  Author: Pankaj Singh

With growing occurrence of liver cancer cases across the globe, the need to find a solution to the ailment is rising s...

Read More
Vertex announces reimbursement of ORKAMBI and SYMDEKO in Australia
  Author: Pankaj Singh

Vertex Pharmaceuticals Inc. is a global biopharmaceutical company that is relentless in striving for medical excellenc...

Read More
Exicure reveals positive data from XCUR17 clinical trial for Psoriasis
  Author: Pankaj Singh

Clinical trials play a vital role in developing new treatments that could immensely improve a person’s living. T...

Read More
Principia Biopharma reveals data from Phase 1/2 trial targeting ITP
  Author: Pankaj Singh

Immune thrombocytopenia (ITP) is a type of blood abnormality that creates a shortage of blood cell fragments know...

Read More
Incyte unveils positive results from Phase 2 ruxolitinib cream study
  Author: Pankaj Singh

Vitiligo is a prominent skin diseases prevalent across the world that causes skin color loss. The disease is increasin...

Read More
ProQR reveals positive results from Phase 1/2 trial of Sepofarsen
  Author: Pankaj Singh

Leber congenital amaurosis (LCA) is a very rare eye condition that can be seen in newborn babies. Currently, the ...

Read More
FDA approves Swiss dermatological company Galderma’s AKLIEF acne cream
  Author: Saipriya Iyer

Skin care is one of the fastest growing concerns of the modern generation and acne is the foremost issue many face in ...

Read More
Bavarian Nordic begins Phase 1 clinical trial of MVA-BN® WEV vaccine
  Author: Pankaj Singh

The trial will reportedly examine the safety, tolerability and immunogenicity of MVA-BN WEV ...

Read More
Illumina inks a long-term NGS deal with Dutch company Qiagen
  Author: Pankaj Singh

The pharmaceutical industry is responsible for treating some of the most critical health issues. The sector produces, ...

Read More
HMS invests $7.5Mn in digital medication management firm MedAdvisor
  Author: Pankaj Singh

Medication adherence or taking medications correctly and on time is one of the most important parts of any treatment. ...

Read More
Graybug Vision commences Phase 2b Clinical study to target wet AMD
  Author: Pankaj Singh

Macular degeneration is the leading cause of irreversible, serious vision loss that occurs when a section of...

Read More
Servier buys PIXUVRI Non-Hodgkin lymphoma therapy from CTI BioPharma
  Author: Saipriya Iyer

A substantial rise in occurrence of cancer cases is being witnessed across the globe lately. Various global pharmaceutical firms are increasingly w...

Read More
Merck reveals positive results from KEYTRUDA® Plus Phase 3 trial
  Author: Pankaj Singh

Breast cancer is initiated when genes regulating cell growth mutate. These mutations allows the cells to divide and mu...

Read More
Treos Bio updates results of phase 1/2 trial of its cancer vaccine
  Author: Pankaj Singh

Vaccine-specific T cell responses were initially anticipated by PEPI test (via the complete HLA genotype of pa...

Read More
Mustang Bio reveals Phase 1 Trial Of MB-105 For Prostate Cancer
  Author: Saipriya Iyer

Prostate cancer (medically referred as prostatic carcinoma) is a type of cancer that is mostly found among m...

Read More
Exact Sciences Cologuard® test gets label expansion approval from FDA
  Author: Pankaj Singh

Colorectal cancer cases are increasingly growing across the world, however it is one of those cancers which can be tre...

Read More
Celltrion’s CT-P13 gets CHMP positive opinion for Rheumatoid Arthritis
  Author: Saipriya Iyer

Rheumatoid Arthritis is a progressive, long-term and a disabling autoimmune disease. Rheumatoid Arthritis affects more...

Read More
XORTX reveals positive results for Phase 2 trial of TMX-049
  Author: Pankaj Singh

Type 2 diabetes is a prevailing disease in which cells become unresponsive to insulin while gradually increasing blood...

Read More
Poxel releases detailed Imeglimin Phase 3 results from TIMES 1 program
  Author: Pankaj Singh

Type 2 diabetes is a prevailing disease in which cells become unresponsive to insulin while gradually increasing blood...

Read More
Poxel commences its Phase 1b trial for NASH drug candidate, PXL065
  Author: Pankaj Singh

Nonalcoholic steatohepatitis (NASH) is liver inflammation caused by the buildup of fat in the liver mostly with people...

Read More
Emergency Care Partners finalizes its merger with Chicago’s IEMS
  Author: Pankaj Singh

With rising cases of roadside accidents worldwide, the need for emergency medical facilities have increased considerab...

Read More
Zelegent expands to OSA therapeutics with MISH platform acquisition
  Author: Pankaj Singh

MISH Technology stands for Minimally Invasive Suspension of the Hyoid and is a novel pre-clinical produ...

Read More
Google to open new office in Rochester under Mayo Clinic partnership
  Author: Saipriya Iyer

This new Google collaboration would involve records such as videos, some reports as well as scans that ...

Read More
4BIO Capital intends to take gene and cell therapies mainstream
  Author: Pankaj Singh

The venture capitalist firm has secured an investment of $50 million and is expecting to gather an investment ...

Read More
Lung Ambition Alliance reveals plans to double lung cancer survival
  Author: Pankaj Singh

New program will be launched to help local initiatives run by patient organizations that contain the ca...

Read More
SunGen Pharma and Elite Pharmaceuticals file an ANDA with the FDA
  Author: Pankaj Singh

This is the second ANDA filed by both the companies, giving Elite Pharmaceutical the exclusive right to retail...

Read More
Ribon Therapeutics doses first patient in RBN-2397 Phase 1 trial
  Author: Pankaj Singh

The Phase 1 clinical trial assessing RBN-2397 will be the first clinical evaluation of monoPARP Inhibit...

Read More
Vertex acquires Semma Therapeutics for $950M to develop diabetes cure
  Author: Pankaj Singh

The acquisition for $950 million has been an all-cash deal.   ...

Read More
Aridis Pharmaceuticals announces results from clinical trial of AR-105
  Author: Saipriya Iyer

Aridis Pharmaceuticals, Inc., a U.S.-based biopharmaceutical company focused on developing innovative anti-infective t...

Read More
Inotrem nangibotide program gets Fast Track designation from the FDA
  Author: Pankaj Singh

The company’s therapeutic solution is capable of being the first septic shock treatment which is mechanism-based. ...

Read More
Immunicum AB reveals positive Phase II MERECA clinical trial data
  Author: Pankaj Singh

Satisfactory safety profile and the positive number of complete responses by the trials firmly justify the pro...

Read More
Regenxbio to present interim update of RGX-314 Phase I/IIA trial
  Author: Pankaj Singh

Dr. Jeffery Heier, the primary investigator of the trial, will present the data during the Retina Subsp...

Read More
Enrollment concluded early in PCS-499 clinical trial for NL treatment
  Author: Pankaj Singh

Clinical stage biopharmaceutical firm Processa Pharmaceuticals Inc today announced the last patient to be enrolled in ...

Read More
Lupins Pharma Dynamics signs distribution agreement with Creso Pharma
  Author: Pankaj Singh

The deal gives Lupin access to Creso’s cannaQIX product range, which are nutraceuticals based on ...

Read More
Altaire’s veterinary ophthalmic products recalled due to QA concerns
  Author: Pankaj Singh

Altaire Pharmaceuticals recalls specific product/lots of ophthalmic drugs created for Dechra Veterinary Products, due to sterility c...

Read More
Mundipharma submits license extension for Invokana & Vokanamet to EMA
  Author: Pankaj Singh

CREDENCE renal outcome study, that was stopped early because of positive efficacy findings, laid the fo...

Read More
Outlook Therapeutics finishes patient registration for NORSE 1 trial
  Author: Pankaj Singh

NORSE 1 has registered a sum of 61 patients from nine different sites in Australia. &nb...

Read More
Biogen & Invitae introduce SMA STAT test for faster genetic testing
  Author: Pankaj Singh

Global biotechnology expert Biogen Inc. and advanced genetics leader Invitae Corporation have reportedly announced the...

Read More
FDA approves Rozlytrek™ for cancer patients with ROS1-positive & NTRK
  Author: Pankaj Singh

FDA approves Rozlytrek™ for cancer patients with ROS1-positive & NTRK ...

Read More